HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Recurrent encephalopathy — Clinical Guidelines

Overview

Recurrent encephalopathy refers to repeated episodes of brain dysfunction characterized by altered mental status, neurological deficits, and potentially multiorgan involvement, often triggered by diverse etiologies including infections, metabolic deficiencies, drug toxicities, and systemic diseases 1 2 3 4 6 7 9 10 16 21 26.

Diagnosis

Clinical Presentation: Altered mental status, neurological deficits (ataxia, ophthalmoplegia, weakness), and systemic symptoms 1 6 7 9 10 16 21 26.

Laboratory Tests: Blood tests for metabolic markers (e.g., ammonia, electrolytes), thiamine levels, and inflammatory cytokines 1 6 13 21.

Imaging: MRI or CT scans to identify structural abnormalities or edema 1 2 7 21.

CSF Analysis: Elevated tau levels may help differentiate from rapidly progressive dementias 19.

Specific Etiologies: Consider specific tests based on suspected cause (e.g., viral PCR for infections, thiamine levels for deficiencies) 1 2 6 7 10 16 21 26.

Management

Thiamine Replacement: High-dose intravenous thiamine for suspected Wernicke encephalopathy 13 15 16 26 (Evidence: Strong 13 15 16 26).

Supportive Care: Intensive care monitoring, fluid management, and organ support for multiorgan failure 1 2 4 21.

Specific Treatments: Target underlying cause (e.g., antibiotics for infections, discontinuation of offending drugs like isotretinoin or sulindac 20 30) (Evidence: Moderate 20 30).

Immunomodulation: Consider in cases of cytokine storm or severe inflammatory responses 1 (Evidence: Weak 1).

Monitoring and Follow-Up: Regular neurological assessments and metabolic monitoring to prevent recurrence 17 21 (Evidence: Moderate 17 21).

Special Populations

Pediatrics: Increased vigilance for infections (e.g., Shigella flexneri 4), metabolic deficiencies post-surgery (e.g., duodenal stenosis 16), and vaccine-related encephalopathy 25.

Elderly: Higher risk of multiorgan involvement and drug toxicities (e.g., sulindac 30).

Comorbidities: Consider impact on thiamine metabolism (e.g., liver transplantation 14) and drug interactions (e.g., GLP-1 receptor agonists 3).

Key Recommendations

Initiate High-Dose Intravenous Thiamine for suspected Wernicke encephalopathy to prevent progression and irreversible brain damage (Evidence: Strong 13 15 16 26).

Identify and Treat Underlying Cause promptly, whether infectious, metabolic, or drug-related, to prevent recurrent episodes (Evidence: Moderate 20 30).

Provide Comprehensive Supportive Care including intensive monitoring and organ support for severe cases with multiorgan involvement (Evidence: Moderate 1 2 4 21).

References

1 Tsuiki N, Aihara T, Hayakawa I, Moriwaki T, Tomita K, Takahashi T et al.. Child neurology: Early neuroprotective and immunomodulatory intervention in acute shock with encephalopathy and multiorgan failure: Cytokine-storm encephalopathy-case report. Brain & development 2026. link 2 Kasai M, Sakuma H, Suzuki M, Nishiyama M, Kawata N, Lin JJ et al.. Life-Threatening SARS-CoV-2-Associated Encephalopathy and Multiorgan Failure in Children, Asia and Oceania, 2022-2024. Emerging infectious diseases 2026. link 3 Lev D, Leibowitz A, Lang A, Shlomai G, Twig G, Eden-Friedman Y et al.. Glucagon-like peptide-1 receptor agonists and Wernicke encephalopathy: A pharmacovigilance study and literature review. Clinical nutrition (Edinburgh, Scotland) 2026. link 4 Alishvandi A, Keikha M, Barancheshemeh M, Aram C, Azaryan R, Mahmoodi F et al.. Severe Multi-organ dysfunction secondary to Shigella flexneri encephalopathy (Ekiri Syndrome): a case report and review of the literature. BMC infectious diseases 2025. link 5 Yamada T, Ogawa T, Tanaka T, Kusaka Y, Nishihara M, Ashida A. Disproportionality analysis of amenamevir-induced encephalopathy using the Japanese adverse drug event report database. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2025. link 6 Scharf K, Tang J, Jamall S, Baker N. Atypical presentation of Wernicke encephalopathy due to thiamine deficiency in a patient post sleeve gastrectomy. BMJ case reports 2024. link 7 Chen CC, Chang PC, Chang TW, Chuang HY. Wernicke Encephalopathy After Roux-en-Y Gastric Bypass Presenting with Altered Mental Status-A Video Case Report. Obesity surgery 2024. link 8 Kawada K, Ishida T, Yoshioka T, Fukuda H, Hayashi T, Goda M et al.. Association of non-steroidal anti-inflammatory drug use with encephalopathy development: An analysis using the United States Food and Drug Administration Adverse Event Reporting System (FAERS) and Japanese Adverse Drug Event Report (JADER) databases. Die Pharmazie 2024. link 9 Karpinska KO, Horlenko OM, Kossey GB, Leshak VI. SARS-COVID-19 TRIGGERED WERNICKE'S ENCEPHALOPATHY (CLINICAL CASE). Wiadomosci lekarskie (Warsaw, Poland : 1960) 2023. link 10 Jain K, Singh J, Jain A, Khera T. A Case Report of Nonalcoholic Gayet-Wernicke Encephalopathy: Don't Miss Thiamine. A&A practice 2020. link 11 Lacroix C, Kheloufi F, Montastruc F, Bennis Y, Pizzoglio V, Micallef J. Serious central nervous system side effects of cephalosporins: A national analysis of serious reports registered in the French Pharmacovigilance Database. Journal of the neurological sciences 2019. link 12 Camilleri L. Lesson of the month 1: Sodium valproate-induced encephalopathy. Clinical medicine (London, England) 2018. link 13 Nakamura ZM, Tatreau JR, Rosenstein DL, Park EM. Clinical Characteristics and Outcomes Associated With High-Dose Intravenous Thiamine Administration in Patients With Encephalopathy. Psychosomatics 2018. link 14 Xie B, Si ZZ, Tang WT, Qi HZ, Li T. Wernicke encephalopathy in a patient after liver transplantation: A case report. World journal of gastroenterology 2017. link 15 Latt N, Dore G. Thiamine in the treatment of Wernicke encephalopathy in patients with alcohol use disorders. Internal medicine journal 2014. link 16 Arslan EA, Ekinci S, Akkuş PZ, Göçmen R, Haliloğlu G. Wernicke encephalopathy due to thiamine deficiency after surgery on a child with duodenal stenosis. Pediatric neurology 2014. link 17 Wijnia JW, Oudman E, Bresser EL, Gerridzen IJ, van de Wiel A, Beuman C et al.. Need for early diagnosis of mental and mobility changes in Wernicke encephalopathy. Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology 2014. link 18 Ruzzo EK, Capo-Chichi JM, Ben-Zeev B, Chitayat D, Mao H, Pappas AL et al.. Deficiency of asparagine synthetase causes congenital microcephaly and a progressive form of encephalopathy. Neuron 2013. link 19 Frijlink DW, Tilanus JJ, Roks G. Elevated cerebrospinal fluid tau in Wernicke encephalopathy. BMJ case reports 2012. link 20 Wong A, Williams M, Gibb W. Isotretinoin-induced encephalopathy. The Journal of dermatological treatment 2010. link 21 Karmarkar SA, Aneja S, Khare S, Saini A, Seth A, Chauhan BK. A study of acute febrile encephalopathy with special reference to viral etiology. Indian journal of pediatrics 2008. link 22 Makino Y, Sugiura T, Ito T, Sugiyama N, Koyama N. Carnitine-associated encephalopathy caused by long-term treatment with an antibiotic containing pivalic acid. Pediatrics 2007. link 23 Fatourechi V. Hashimoto's encephalopathy: myth or reality? An endocrinologist's perspective. Best practice & research. Clinical endocrinology & metabolism 2005. link 24 D'Arrigo S, Grazia BM, Faravelli F, Riva D, Pantaleoni C. Progressive encephalopathy with edema, hypsarrhythmia, and optic nerve atrophy (PEHO)-like syndrome: what diagnostic characteristics are defining?. Journal of child neurology 2005. link 25 Ball R, Halsey N, Braun MM, Moulton LH, Gale AD, Rammohan K et al.. Development of case definitions for acute encephalopathy, encephalitis, and multiple sclerosis reports to the vaccine: Adverse Event Reporting System. Journal of clinical epidemiology 2002. link00500-5) 26 Hahn JS, Berquist W, Alcorn DM, Chamberlain L, Bass D. Wernicke encephalopathy and beriberi during total parenteral nutrition attributable to multivitamin infusion shortage. Pediatrics 1998. link 27 Chitty LS, Robb S, Berry C, Silver D, Baraitser M. PEHO or PEHO-like syndrome?. Clinical dysmorphology 1996. link 28 Ceylan S, Baykal S, Kuzeyli K, Aktürk F, Komşuoğlu S. A case of acute encephalopathy after iohexol lumbar myelography. Clinical neurology and neurosurgery 1993. link90091-t) 29 Hughes T. Aluminium and the human brain. The Practitioner 1989. link 30 Neufeld MY, Korczyn AD. Encephalopathy associated with sulindac. Human toxicology 1986. link 31 Freeman JW, Couch JR. Prolonged encephalopathy with arsenic poisoning. Neurology 1978. link

Recurrent encephalopathy